Journal subscriptions are complimentary for members.
CLI Global, the official publication of the Critical Limb Ischemia Global Society provides educational articles, case studies, and news led by experts and key opinion leaders in the field of CLI and amputation prevention.
Society members have online access to all previous journals. Login to view and/or download previous issues in the Journal Archives.
Journal of Critical Limb Ischemia is the only peer-reviewed journal dedicated to advancing the treatment of critical limb ischemia.
The goal of the journal is to provide an international forum for the presentation of original ideas and recent results related to all aspects of diagnostic, therapeutic, and pathophysiologic aspects of critical limb ischemia. These articles will likely substantially influence the clinical practice of treating the co-morbidities present in patients presenting with advanced disease.
Content: Journal of Critical Limb Ischemia is the official journal of the CLI Global Society. JCLI is the first and only academic journal to focus on interventional techniques pertaining to the complex disease known as critical limb ischemia. Priority is given to original research and on randomized trials and registry studies. In addition, pharmacological, diagnostic, and pathophysiological aspects of this disease are given special attention in this online-only journal.
ISSN 2694-3026
Website: clijournal.com
Editor-in-Chief: Jihad A. Mustapha, MD
Frequency: Quarterly
The CLI Global Society Multidisciplinary Roundtable Discussion on BEST-CLI: Implications of the Available Data Moderator/Interviewer: Barry T. Katzen, MD, FACR, FACC, FSIR, President of the CLI Global Society Roundtable Participants: Walter Dorigo, MD; Anahita Dua, MBCHB, MBA, MSc; Andrew Holden, MBChB, FRANZCR, EBIR, ONZM; Robert Lookstein, MD, MHCDL, FSIR, FAHA,
The BEST-CLI Trial: Time for Pause or Action? Fadi A. Saab, MD; Konstantinos Stavroulakis, MD; Jos C. van den Berg, MD, PhD; Thomas Zeller, MD, PhD; Jihad A. Mustapha, MD; Barry T. Katzen, MD; Andrew Holden, MBChB; Walter Dorigo, MD; Richard F. Neville, MD; The initial results of the long-awaited